Piperine Ameliorates Trimellitic Anhydride-Induced Atopic Dermatitis-Like Symptoms by Suppressing Th2-Mediated Immune Responses Via Inhibition of STAT6 Phosphorylation

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2020 May 13

PMID 32392825

Citations 6

Authors

Dae Woon Choi

Sun Young Jung

Dong-Hwa Shon

Hee Soon Shin

Affiliations

Soon will be listed here.

Abstract

Atopic dermatitis (AD) is a common inflammatory skin disease predominately related to Type 2 helper T (Th2) immune responses. In this study, we investigated whether piperine is able to improve AD symptoms using a trimellitic anhydride (TMA)-induced AD-like mouse model. Topical treatment with piperine reduced ear swelling (ear thickness and epidermal thickness) induced by TMA exposure. Furthermore, piperine inhibited pro-inflammatory cytokines such as TNF-α and IL-1β in mouse ears, compared with the TMA-induced AD group. In measuring allergic immune responses in draining lymph nodes (dLNs), we found that IL-4 secretion, GATA3 mRNA level, and STAT6 phosphorylation were suppressed by piperine treatment. In an ex vivo study, piperine also inhibited the phosphorylation of STAT6 on the CD4 T cells isolated from splenocytes of BALB/c mice, and piperine suppressed IL-4-induced CCL26 mRNA expression and STAT6 phosphorylation in human keratinocytes resulting in the inhibition of infiltration of CCR3 cells into inflammatory lesions. These results demonstrate that piperine could ameliorate AD symptoms through suppression of Th2-mediated immune responses, including the STAT6/GATA3/IL-4 signaling pathway. Therefore, we suggest that piperine is an excellent candidate as an inhibitor of STAT6 and may help to improve AD symptoms.

Citing Articles

Natural Compounds as Protease Inhibitors in Therapeutic Focus on Cancer Therapy.

Kakali B Anticancer Agents Med Chem. 2024; 24(16):1167-1181.

PMID: 38988167 DOI: 10.2174/0118715206303964240708095110.

Comprehensive Review on Phytoconstituents-based Nanomedicine for the Treatment of Atopic Dermatitis.

Varshney M, Bahadur S Curr Pharm Biotechnol. 2023; 25(6):737-756.

PMID: 37888809 DOI: 10.2174/0113892010245092230922180341.

Nanotechnology-Based Topical Delivery of Natural Products for the Management of Atopic Dermatitis.

Marques M, Varela C, Mendonca L, Cabral C Pharmaceutics. 2023; 15(6).

PMID: 37376172 PMC: 10302414. DOI: 10.3390/pharmaceutics15061724.

Perspectives of herbs and their natural compounds, and herb formulas on treating diverse diseases through regulating complicated JAK/STAT signaling.

Chen J, Tian X, Wei S, Yang Y, Deng S, Jiao C Front Pharmacol. 2022; 13:993862.

PMID: 36324680 PMC: 9619051. DOI: 10.3389/fphar.2022.993862.

Natural Products and Skin Diseases.

Majtan J, Bucekova M, Jesenak M Molecules. 2021; 26(15).

PMID: 34361642 PMC: 8348257. DOI: 10.3390/molecules26154489.

References

Nelms K, Keegan A, Zamorano J, Ryan J, Paul W . The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol. 1999; 17:701-38. DOI: 10.1146/annurev.immunol.17.1.701. View

Kaplan D, Igyarto B, Gaspari A . Early immune events in the induction of allergic contact dermatitis. Nat Rev Immunol. 2012; 12(2):114-24. PMC: 3578582. DOI: 10.1038/nri3150. View

Leung D, Boguniewicz M, Howell M, Nomura I, Hamid Q . New insights into atopic dermatitis. J Clin Invest. 2004; 113(5):651-7. PMC: 351324. DOI: 10.1172/JCI21060. View

Kimber I, Cumberbatch M . Stimulation of Langerhans cell migration by tumor necrosis factor alpha (TNF-alpha). J Invest Dermatol. 1992; 99(5):48S-50S. DOI: 10.1111/1523-1747.ep12668986. View

Arndt J, Smith N, Tausk F . Stress and atopic dermatitis. Curr Allergy Asthma Rep. 2008; 8(4):312-7. DOI: 10.1007/s11882-008-0050-6. View

Aversa G, Punnonen J, Cocks B, de Waal Malefyt R, Vega Jr F, Zurawski S . An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors. J Exp Med. 1993; 178(6):2213-8. PMC: 2191286. DOI: 10.1084/jem.178.6.2213. View

Akdis C, Akdis M, Bieber T, Bindslev-Jensen C, Boguniewicz M, Eigenmann P . Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. Allergy. 2006; 61(8):969-87. DOI: 10.1111/j.1398-9995.2006.01153.x. View

Lv J, Xiong Y, Li W, Cui X, Cheng X, Leng Q . IL-37 inhibits IL-4/IL-13-induced CCL11 production and lung eosinophilia in murine allergic asthma. Allergy. 2018; 73(8):1642-1652. DOI: 10.1111/all.13395. View

Arkwright P, Chase J, Babbage S, Pravica V, David T, Hutchinson I . Atopic dermatitis is associated with a low-producer transforming growth factor beta(1) cytokine genotype. J Allergy Clin Immunol. 2001; 108(2):281-4. DOI: 10.1067/mai.2001.117259. View

10.

Czarnowicki T, Esaki H, Gonzalez J, Malajian D, Shemer A, Noda S . Early pediatric atopic dermatitis shows only a cutaneous lymphocyte antigen (CLA)(+) TH2/TH1 cell imbalance, whereas adults acquire CLA(+) TH22/TC22 cell subsets. J Allergy Clin Immunol. 2015; 136(4):941-951.e3. PMC: 4946641. DOI: 10.1016/j.jaci.2015.05.049. View

11.

Glimcher L, Murphy K . Lineage commitment in the immune system: the T helper lymphocyte grows up. Genes Dev. 2000; 14(14):1693-711. View

12.

Greenshields A, Doucette C, Sutton K, Madera L, Annan H, Yaffe P . Piperine inhibits the growth and motility of triple-negative breast cancer cells. Cancer Lett. 2014; 357(1):129-140. DOI: 10.1016/j.canlet.2014.11.017. View

13.

Stirling R, van Rensen E, Barnes P, Chung K . Interleukin-5 induces CD34(+) eosinophil progenitor mobilization and eosinophil CCR3 expression in asthma. Am J Respir Crit Care Med. 2001; 164(8 Pt 1):1403-9. DOI: 10.1164/ajrccm.164.8.2010002. View

14.

Suarez-Farinas M, Dhingra N, Gittler J, Shemer A, Cardinale I, de Guzman Strong C . Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis. J Allergy Clin Immunol. 2013; 132(2):361-70. PMC: 3991240. DOI: 10.1016/j.jaci.2013.04.046. View

15.

Ying X, Chen X, Cheng S, Shen Y, Peng L, Xu H . Piperine inhibits IL-β induced expression of inflammatory mediators in human osteoarthritis chondrocyte. Int Immunopharmacol. 2013; 17(2):293-9. DOI: 10.1016/j.intimp.2013.06.025. View

16.

Eaton L, Roberts R, Kimber I, Dearman R, Metryka A . Skin sensitization induced Langerhans' cell mobilization: variable requirements for tumour necrosis factor-α. Immunology. 2014; 144(1):139-48. PMC: 4264917. DOI: 10.1111/imm.12359. View

17.

Daugherty B, Siciliano S, DeMartino J, Malkowitz L, Sirotina A, Springer M . Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J Exp Med. 1996; 183(5):2349-54. PMC: 2192548. DOI: 10.1084/jem.183.5.2349. View

18.

Bui T, Piao C, Song C, Shin H, Shon D, Chai O . Piper nigrum extract ameliorated allergic inflammation through inhibiting Th2/Th17 responses and mast cells activation. Cell Immunol. 2017; 322:64-73. DOI: 10.1016/j.cellimm.2017.10.005. View

19.

Yang J . Topical application of fucoidan improves atopic dermatitis symptoms in NC/Nga mice. Phytother Res. 2012; 26(12):1898-903. DOI: 10.1002/ptr.4658. View

20.

Kaplan M, Schindler U, Smiley S, Grusby M . Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity. 1996; 4(3):313-9. DOI: 10.1016/s1074-7613(00)80439-2. View